Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

TARA holding history

Protara Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TARA overviewAll 13F holders of TARAFull Q2 2026 holdings

Shares (Q2 2026)
456,773
Value
$1.74M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of TARA by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026456,773$1.74M<0.1%−945,640−67.4%ReducedHolders
Q1 20261,402,413$7.31M<0.1%+186,876+15.4%AddedHolders
Q4 20251,215,537$6.48M<0.1%+372,463+44.2%AddedHolders
Q3 2025843,074$3.67M<0.1%−292,693−25.8%ReducedHolders
Q2 20251,135,767$3.44M<0.1%+499,093+78.4%AddedHolders
Q1 2025636,674$2.71M<0.1%+487,266+326.1%AddedHolders
Q4 2024149,408$788.9K<0.1%+141,990+1,914.1%AddedHolders
Q3 20247,418$13.6K<0.1%+7,418NewHolders
Q2 20240$00.0%−3,725−100.0%Sold outHolders
Q1 20243,725$14.9K<0.1%+2,809+306.7%AddedHolders
Q4 2023916$1.72K<0.1%+795+657.0%AddedHolders
Q3 2023121$202<0.1%+121NewHolders
Q2 20230$00.0%−971−100.0%Sold outHolders
Q1 2023971$3.04K<0.1%−1,329−57.8%ReducedHolders
Q4 20222,300$6.16K<0.1%+2,061+862.3%AddedHolders
Q3 2022239$1.00K<0.1%−1,032−81.2%ReducedHolders
Q2 20221,271$4.00K<0.1%+697+121.4%AddedHolders
Q1 2022574$3.00K<0.1%+574NewHolders
Q3 20210$00.0%−99−100.0%Sold outHolders
Q2 202199$1.00K<0.1%−1,338−93.1%ReducedHolders
Q1 20211,437$23.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.